Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals Ownership Summary
Ionis Pharmaceuticals is owned by 122.10% institutional investors, 0.61% insiders. Dld asset management, lp is the largest institutional shareholder, holding 15.71% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.84% of its assets in Ionis Pharmaceuticals shares.
IONS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ionis Pharmaceuticals | 122.10% | 0.61% | -22.71% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Dld asset management, lp | 25.00M | 15.71% | $34.63B |
| Fmr | 23.69M | 14.89% | $1.55B |
| Vanguard group | 16.48M | 10.36% | $1.08B |
| T. rowe price investment management | 13.16M | 8.27% | $860.73M |
| Capital world investors | 12.72M | 7.99% | $832.32M |
| Blackrock | 10.32M | 7.09% | $491.90M |
| Blackrock funding, inc. /de | 10.45M | 6.57% | $683.50M |
| Wellington management group llp | 6.59M | 4.14% | $431.04M |
| Lombard odier asset management (europe) | 6.49M | 4.08% | $8.96M |
| Bellevue group | 6.24M | 3.92% | $408.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tweedy, browne | 2.89M | 10.60% | $114.26M |
| Boone capital management | 417.83K | 8.96% | $27.33M |
| Bellevue group | 6.24M | 8.49% | $408.51M |
| Deep track capital, lp | 3.81M | 6.95% | $249.13M |
| Exome asset management | 131.02K | 5.19% | $8.57M |
| Orion investment | 224.71K | 4.67% | $14.70M |
| Sector gamma as | 270.96K | 4.40% | $17.73M |
| Capricorn fund managers | 162.80K | 3.58% | $10.65M |
| Vestal point capital, lp | 1.07M | 3.18% | $70.33M |
| Privium fund management b.v. | 248.89K | 2.93% | $16.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Dld asset management, lp | 25.00M | 2.48% | 25.00M |
| Lombard odier asset management (europe) | 6.49M | 0.45% | 6.49M |
| Deerfield management company, l.p. (series c) | 1.98M | 1.98% | 1.98M |
| Norges bank | 1.71M | 0.01% | 1.71M |
| Marshall wace, llp | 958.83K | 0.06% | 945.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 13.16M | 0.53% | -2.89M |
| Orbimed advisors | - | - | -2.54M |
| Adage capital partners gp | 1.31M | 0.14% | -2.48M |
| Bvf inc/il | - | - | -1.91M |
| Clearbridge investments | - | - | -1.62M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Dld asset management, lp | 25.00M | 2.48% | 25.00M | $34.63B |
| Lombard odier asset management (europe) | 6.49M | 0.45% | 6.49M | $8.96M |
| Deerfield management company, l.p. (series c) | 1.98M | 1.98% | 1.98M | $129.51M |
| Norges bank | 1.71M | 0.01% | 1.71M | $59.95M |
| Balyasny asset management | 768.65K | 0.05% | 768.65K | $30.37M |
Sold Out
| Holder | Change |
|---|---|
| Activest wealth management | -1.00 |
| Mv capital management | -3.00 |
| Wealthtrak capital management | -5.00 |
| Hexagon capital partners | -9.00 |
| Voisard asset management group | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 449 | 17.23% | 194,303,017 | 14.72% | 122 | 1.08% | 241 | 17.56% | 115 | 6.48% |
| Jun 30, 2025 | 379 | 3.55% | 169,594,655 | 1.94% | 106 | 0.97% | 201 | 28.85% | 108 | -14.29% |
| Mar 31, 2025 | 15 | -96.08% | 14,001,670 | -91.30% | 8 | 0.08% | 6 | -96.65% | 6 | -94.92% |
| Dec 31, 2024 | 235 | -38.48% | 100,254,792 | -35.75% | 67 | 0.61% | 111 | -39.34% | 73 | -31.78% |
| Sep 30, 2024 | 378 | 0.27% | 156,005,896 | 8.92% | 104 | 1.08% | 182 | 3.41% | 106 | -17.83% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 10.91M | 6.84% | 14.25K |
| Fidelity Growth Compy Commingled Pl O | 9.71M | 6.16% | 90.97K |
| BB Biotech AG Ord | 7.85M | 4.97% | - |
| Fidelity Growth Company Fund | 7.70M | 4.83% | -46.11K |
| T. Rowe Price US Mid-Cap Growth Equity | 5.99M | 3.77% | 300.20K |
| T. Rowe Price Mid-Cap Growth | 5.98M | 3.75% | -11.00K |
| Vanguard Total Stock Mkt Idx Inv | 4.77M | 2.99% | -99.81K |
| American Funds SMALLCAP World A | 4.57M | 2.87% | 108.08K |
| Vanguard US Total Market Shares ETF | 4.50M | 2.83% | 256.36K |
| Vanguard Health Care Inv | 3.99M | 2.50% | -1.74M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 01, 2025 | WENDER JOSEPH H | - | Sell | $603.49K |
| Dec 01, 2025 | WENDER JOSEPH H | - | Sell | $1.66M |
| Nov 25, 2025 | KLEIN JOSEPH III | - | Sell | $320.00K |
| Nov 25, 2025 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | $1.36M |
| Nov 19, 2025 | HERMAN JOAN E | - | Sell | $2.31M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 33 |
| 2025 Q3 | - | 40 |
| 2025 Q2 | 1 | 3 |
| 2025 Q1 | - | 23 |
| 2024 Q4 | 2 | 4 |
IONS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools